Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines less effective and treatment options are scarce. Randomized tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Denkinger, Claudia M., Janssen, Maike, Schäkel, Ulrike, Gall, Julia, Leo, Albrecht, Stelmach, Patrick, Weber, Stefan F., Krisam, Johannes, Baumann, Lukas, Stermann, Jacek, Merle, Uta, Weigand, Markus A., Nusshag, Christian, Bullinger, Lars, Schrezenmeier, Jens-Florian, Bornhäuser, Martin, Alakel, Nael, Witzke, Oliver, Wolf, Timo, Vehreschild, Maria J. G. T., Schmiedel, Stefan, Addo, Marylyn M., Herth, Felix, Kreuter, Michael, Tepasse, Phil-Robin, Hertenstein, Bernd, Hänel, Mathias, Morgner, Anke, Kiehl, Michael, Hopfer, Olaf, Wattad, Mohammad-Amen, Schimanski, Carl C., Celik, Cihan, Pohle, Thorsten, Ruhe, Matthias, Kern, Winfried V., Schmitt, Anita, Lorenz, Hanns-Martin, Souto-Carneiro, Margarida, Gaeddert, Mary, Halama, Niels, Meuer, Stefan, Kräusslich, Hans-Georg, Müller, Barbara, Schnitzler, Paul, Parthé, Sylvia, Bartenschlager, Ralf, Gronkowski, Martina, Klemmer, Jennifer, Schmitt, Michael, Dreger, Peter, Kriegsmann, Katharina, Schlenk, Richard F., Müller-Tidow, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886549/
https://www.ncbi.nlm.nih.gov/pubmed/36581734
http://dx.doi.org/10.1038/s43018-022-00503-w

Ejemplares similares

Ejemplares similares